Journal
AUSTRALASIAN PSYCHIATRY
Volume 22, Issue 6, Pages 573-575Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/1039856214556327
Keywords
sertraline; selective serotonin reuptake inhibitor; drug-induced; ocular toxicity; maculopathy
Categories
Ask authors/readers for more resources
Objective: We report a rare case of bilateral maculopathy that developed with the initiation of sertraline. Methods: We conducted a case report and review of the literature. Results: A 23-year-old man rapidly developed maculopathy with associated visual blurring after the initiation of sertraline. Treatment was ceased with the patient subsequently reporting mild improvement in visual symptoms. Conclusions: Maculopathy associated with sertraline use has yet to be established and recognized as an adverse side effect. With only one previous reported case in the literature, this condition requires further awareness.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available